Harrow HROW
NASDAQ HROW
$37.89 +0.04 (+0.11%)
As of: Sep 9, 2026 · 1:47 PM EDT

Harrow (HROW) EV to FCF (2010 - 2026)

Harrow (HROW) posted EV to FCF of 147.15 for Q2 2026, down 10.88% on a QoQ basis from 132.71 in Q1 2026, and up 86.65% year-over-year from 78.84 in Q2 2025.

Analysis

Harrow (HROW) EV to FCF (2010 - 2026) Analysis & Trends

Harrow has reported EV to FCF for 17 years, with the latest figure at 147.15 in Q2 2026.

  • On a quarterly basis, EV to FCF rose 86.65% year-over-year to 147.15 in Q2 2026; TTM through Jun 2026 was 300.58, a 28.45% decrease from a year earlier, with the FY2025 full-year figure at 40.74, up 184.49% from the prior year.
  • EV to FCF was 147.15 for Q2 2026 at Harrow, down from 132.71 in the prior quarter.
  • The five-year high for EV to FCF was 651.1 in Q3 2024, with the low at 1102.11 in Q2 2025.
  • Average EV to FCF over 5 years is 48.73, with a median of 66.24 recorded in 2024.
  • The largest YoY upside for EV to FCF was 446.65% in 2025 against a maximum downside of 408.41% in 2025.
  • Over 5 years, EV to FCF stood at 73.89 in 2022, then jumped by 149.47% to 36.55 in 2023, then slumped by 271.24% to 62.59 in 2024, then soared by 446.65% to 216.97 in 2025, then slumped by 167.82% to 147.15 in 2026.
  • The last three EV to FCF figures came in at 147.15 (Q2 2026), 132.71 (Q1 2026), and 216.97 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.47 Bn 624.71 Bn 17.26 Bn
2 AbbVie 439.99 Bn 433.42 Bn 12.70 Bn
3 Merck 365.45 Bn 358.31 Bn 12.21 Bn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn
7 Revolution Medicines 44.23 Bn 44.23 Bn -
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn
10 Harrow 1.42 Bn 1.33 Bn 50.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -147.15
Mar 31, 2026 -132.71
Dec 31, 2025 216.97
Sep 30, 2025 104.39
Jun 30, 2025 -1,102.11
Mar 31, 2025 45.20
Dec 31, 2024 -62.59
Sep 30, 2024 651.10
Jun 30, 2024 -216.78
Mar 31, 2024 -83.00
Dec 31, 2023 36.55
Sep 30, 2023 -249.08
Jun 30, 2023 126.61
Mar 31, 2023 -69.89
Dec 31, 2022 -73.89
Sep 30, 2022 -189.29
Jun 30, 2022 31.54
Mar 31, 2022 236.96
Dec 31, 2021 -111.50
Sep 30, 2021 -74.56